{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:07:46Z","timestamp":1792843666151,"version":"4.5.0"},"reference-count":21,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Longer-term survival is possible for some patients with anaplastic thyroid cancer (ATC). However, genomic factors associated with improved survival are poorly characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop a mathematical model to predict mutation-based survival risk in ATC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective cohort study of 204 ATC samples from the cBioPortal database, divided into 80% training and 20% validation cohorts. Multivariate analysis identified prognostic genes, used to construct a point-based risk model. KEGG pathway enrichment and BRAF subanalyses were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Multi-institutional, international genomic database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients or Other Participants<\/jats:title>\n                    <jats:p>Samples were included if sequencing and survival data were available (n = 204).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention(s)<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measure(s)<\/jats:title>\n                    <jats:p>The prespecified primary outcome was overall survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fourteen genes were associated with increased risk: TET1, MAPK12, ATP10A, PIK3CA, MUC4, PNPLA2, PLD4, EGLN2, BSN, FLNC, RADIL, ZMYND8, FRAS1, RECQL4. More aggressive (n = 37) and less aggressive cohorts (n = 128) were determined using the maximally selected rank statistic, yielding a point threshold of 0.27. The predictive performance of the risk model demonstrated a C-index of 0.74. On Kaplan-Meier analysis, 1-year survival differed for more aggressive patients (0%) compared to less aggressive patients (32%). For the validation cohort, survival remained significantly different between risk cohorts and on BRAF subanalysis. Each risk cohort subsequently underwent KEGG pathway enrichment analysis, which showed significantly increased enrichment across several pathways for more aggressive tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This model identifies mutated genes that are associated with the most aggressive ATCs and thus may aid in preoperative risk assessment when evaluating patients for surgery for curative intent.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf391","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T13:13:19Z","timestamp":1752585199000},"page":"382-387","source":"Crossref","is-referenced-by-count":1,"title":["Long-term Survivors of Anaplastic Thyroid Cancer: A Genomic Predictive Model"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8986-7469","authenticated-orcid":false,"given":"Benjamin C","family":"Greenspun","sequence":"first","affiliation":[{"name":"Department of Surgery, Weill Cornell Medicine , New York, NY 10065 ,","place":["USA"]},{"name":"Weill Cornell Medicine, Center for Genomic Health , New York, NY 10065 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Aryeh","family":"Metzger","sequence":"additional","affiliation":[{"name":"Department of Surgery, Weill Cornell Medicine , New York, NY 10065 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Surgery, Weill Cornell Medicine , New York, NY 10065 ,","place":["USA"]},{"name":"Weill Cornell Medicine, Center for Genomic Health , New York, NY 10065 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley E","family":"Pearson","sequence":"additional","affiliation":[{"name":"Department of Surgery, Weill Cornell Medicine , New York, NY 10065 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin H","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Surgery, Weill Cornell Medicine , New York, NY 10065 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6294-5187","authenticated-orcid":false,"given":"Shuibing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Surgery, Weill Cornell Medicine , New York, NY 10065 ,","place":["USA"]},{"name":"Weill Cornell Medicine, Center for Genomic Health , New York, NY 10065 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2548-5764","authenticated-orcid":false,"given":"Rasa","family":"Zarnegar","sequence":"additional","affiliation":[{"name":"Department of Surgery, Weill Cornell Medicine , New York, NY 10065 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Fahey III","sequence":"additional","affiliation":[{"name":"Department of Surgery, Weill Cornell Medicine , New York, NY 10065 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan M","family":"Finnerty","sequence":"additional","affiliation":[{"name":"Department of Surgery, Weill Cornell Medicine , New York, NY 10065 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"issue":"3","key":"2026012101525275800_dgaf391-B1","doi-asserted-by":"crossref","first-page":"113826","DOI":"10.1016\/j.celrep.2024.113826","article-title":"The genomic and evolutionary landscapes of anaplastic thyroid carcinoma","volume":"43","author":"Zeng","year":"2024","journal-title":"Cell Rep"},{"issue":"4","key":"2026012101525275800_dgaf391-B2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.annonc.2021.12.014","article-title":"Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study","volume":"33","author":"Subbiah","year":"2022","journal-title":"Ann Oncol"},{"issue":"8","key":"2026012101525275800_dgaf391-B3","doi-asserted-by":"crossref","first-page":"103648","DOI":"10.1016\/j.esmoop.2024.103648","article-title":"Treatments and clinical outcomes in stage II colon cancer patients with 12-gene oncotype DX colon recurrence score\u00ae assay-guided therapy: real-world data","volume":"9","author":"Brenner","year":"2024","journal-title":"ESMO Open"},{"issue":"1","key":"2026012101525275800_dgaf391-B4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-013-2666-z","article-title":"The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis","volume":"141","author":"Carlson","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2026012101525275800_dgaf391-B5","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J Clin Invest"},{"issue":"5","key":"2026012101525275800_dgaf391-B6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"269","key":"2026012101525275800_dgaf391-B7","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"issue":"23","key":"2026012101525275800_dgaf391-B8","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","article-title":"Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal","volume":"83","author":"de Bruijn","year":"2023","journal-title":"Cancer Res"},{"key":"2026012101525275800_dgaf391-B9","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3389\/fonc.2018.00584","article-title":"The prognostic significance of low-frequency somatic mutations in metastatic cutaneous melanoma","volume":"8","author":"Zhao","year":"2019","journal-title":"Front Oncol"},{"issue":"6","key":"2026012101525275800_dgaf391-B10","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/bioinformatics\/btp041","article-title":"Genome-wide association analysis by lasso penalized logistic regression","volume":"25","author":"Wu","year":"2009","journal-title":"Bioinformatics"},{"issue":"1","key":"2026012101525275800_dgaf391-B11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13073-022-01024-y","article-title":"A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape","volume":"14","author":"Long","year":"2022","journal-title":"Genome Med"},{"issue":"2","key":"2026012101525275800_dgaf391-B12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"issue":"6","key":"2026012101525275800_dgaf391-B13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3892\/ol.2022.13565","article-title":"Pan-cancer analysis supports MAPK12 as a potential prognostic and immunotherapeutic target in multiple tumor types, including in THCA","volume":"24","author":"Wang","year":"2022","journal-title":"Oncol Lett"},{"issue":"2","key":"2026012101525275800_dgaf391-B14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ejhg.2008.154","article-title":"The mutation spectrum in RECQL4 diseases","volume":"17","author":"Siitonen","year":"2009","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"2026012101525275800_dgaf391-B15","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3390\/molecules26041083","article-title":"Regulation of ZMYND8 to treat cancer","volume":"26","author":"Chen","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"2026012101525275800_dgaf391-B16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s13046-019-1334-5","article-title":"TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt\/\u03b2-catenin signaling pathway to suppress EMT in pancreatic tumor cells","volume":"38","author":"Wu","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"2026012101525275800_dgaf391-B17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3389\/fgene.2019.00909","article-title":"Mutations in KIAA1109, CACNA1C, BSN, AKAP13, CELSR2, and HELZ2 are associated with the prognosis in endometrial cancer","volume":"10","author":"Qiao","year":"2019","journal-title":"Front Genet"},{"issue":"2","key":"2026012101525275800_dgaf391-B18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/onc.2017.327","article-title":"Membrane mucin muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer","volume":"37","author":"Rowson-Hodel","year":"2018","journal-title":"Oncogene"},{"issue":"8","key":"2026012101525275800_dgaf391-B19","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41416-019-0413-x","article-title":"High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme","volume":"120","author":"Kamil","year":"2019","journal-title":"Br J Cancer"},{"issue":"17","key":"2026012101525275800_dgaf391-B20","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.3390\/cancers15174327","article-title":"Type IV P-Type ATPases: recent updates in cancer development, progression, and treatment","volume":"15","author":"Yazlovitskaya","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2026012101525275800_dgaf391-B21","doi-asserted-by":"publisher","first-page":"6787","DOI":"10.18632\/oncotarget.14290","article-title":"Egln2 contributes to triple negative breast tumorigenesis by functioning as a substrate for the FBW7 tumor suppressor","volume":"8","author":"Takada","year":"2017","journal-title":"Oncotarget"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf391\/63772027\/dgaf391.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/2\/382\/63772027\/dgaf391.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/2\/382\/63772027\/dgaf391.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:53:22Z","timestamp":1768978402000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/2\/382\/8202978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,7,15]]},"published-print":{"date-parts":[[2026,1,21]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf391","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,7,15]]}}}